Na Lu

8.4k citations

155 papers · 7.4k · 1 hit paper · h-index 50

Impact in

Pharmacology top 0.5%
- Flavonoids in Medical Research
Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism

Papers in

Pharmacology 75
- Flavonoids in Medical Research 74
Cancer Research 19
- Cancer, Hypoxia, and Metabolism 10
- Protease and Inhibitor Mechanisms 7

Co-authors: Qinglong Guo (113 shared papers)Qi-Dong You (61 shared papers)Qi Qi (30 shared papers)Zhiyu Li (45 shared papers)Yong Yang (22 shared papers)Li Zhao (21 shared papers)Xiuming Song (13 shared papers)Hong-Yan Gu (15 shared papers)
Journals: Cancer Letters (8 papers)Molecular Carcinogenesis (8 papers)Oncotarget (8 papers)Toxicology (7 papers)European Journal of Pharmacology (5 papers)
Partner nations: China United States Macao

In The Last Decade

Na Lu

153 papers receiving 7.3k citations

Na Lu's Hit Papers

align trajectories log scale

The Application of Ferroptosis in Diseases 2020 · 346 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2020 Pharmacological Research

Peers

Countries citing papers authored by Na Lu

Since Specialization

Citations

This map shows the geographic impact of Na Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Lu more than expected).

Fields of papers citing papers by Na Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Lu. The network helps show where Na Lu may publish in the future.

Co-authors

The 25 scholars most cited alongside Na Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Na Lu Line = papers co-authored together Na Lu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Application of Ferroptosis in Diseases Pharmacological Research ·Yangmin Qiu, Yue Cao, Wangjia Cao, Na Lu +1 other Hit paper breakdown →	2020	346
2	Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1 Gene ·Binyan Lin, Xiuming Song, Dawei Yang, Bai Dongsheng, Yuyuan Yao, Na Lu	2018	315
3	HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway Cell Death and Differentiation ·Lei Qiang, Tao Wu, Na Lu, Rong Hu, Li Zhao, F-H Chen, X-T Wang, Q-D You	2011	262
4	Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells Biochemical and Biophysical Research Communications ·Yong Yang, Na Lu, Qi-Dong You, Sen Wang, Ying Gao, Yan Chen, Qinglong Guo +1 other	2007	216
5	Isolation and characterization of cancer stem like cells in human glioblastoma cell lines Cancer Letters ·Lei Qiang, Yong Yang, Yanjun Ma, Feihong Chen, Lingbo Zhang, Wei Liu, Qi Qi, Na Lu	2009	181
6	Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells Cancer Letters ·Ling Wang, Yan Chen, Cheng-Ling Li, Feng Feng, Qi-Dong You, Na Lu, Qinglong Guo +1 other	2010	173
7	Anti-hepatitis B virus activity of wogonin in vitro and in vivo Antiviral Research ·Qinglong Guo, Li Zhao, Qi-Dong You, Yong Yang, Hong-Yan Gu, Song GuoLiang, Na Lu, Jian Xin	2007	156
8	Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation Biochemical Pharmacology ·Yang Sun, Yue Zhao, Jing Yao, Li Zhao, Zhao‐Qiu Wu, Yu Wang, Di Pan, Hanchi Miao	2015	135
9	Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma Cell Death and Disease ·Yu Zhou, Li Zhao, Na Lu, Q-L Guo +4 others	2013	122
10	Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase Archives of Virology ·Yue Ding, Zaijin Teng, Jie Yu, Tingting Wang, Na Lu, Hui Wang, Changlin Zhou +1 other	2014	110
11	Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo Toxicology ·Huanan Li, Fei-Fei Nie, Wei Liu, Qinsheng Dai, Na Lu, Qi Qi, Zhiyu Li, Qi-Dong You	2008	97
12	Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells Toxicology ·Licheng He, Na Lu, Qinsheng Dai, Yue Zhao, Li Zhao, Hu Wang, Zhiyu Li, Qi-Dong You	2013	96
13	Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer Nature Cell Biology ·Na Lu, Zhiping Liu, Rong Fu, Wen-Cong Lv, Yi-Wei Zhang, Xiao-Jun Xu, R. Grant Rowe, Yong-Shun Lin	2016	96
14	Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1 Cancer Letters ·Na Lu, Yong Yang, Qi-Dong You, Ying Gao, Hong-Yan Gu, Li Zhao, Xuemin Wang, Qinglong Guo +1 other	2007	91
15	Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2 Life Sciences ·Na Lu, Ying Gao, Yan Chen, Yong Yang, Hong-Yan Gu, Qi Qi, Wei Liu, Xiaotang Wang	2008	88
16	MnO2-Based Nanoplatform Serves as Drug Vehicle and MRI Contrast Agent for Cancer Theranostics ACS Applied Materials & Interfaces ·Mei Zhang, Lei Xing, Hengte Ke, Yujing He, Peng‐Fei Cui, Yong Zhu, Ge Jiang, Jian-Bin Qiao	2017	88
17	Reactive oxygen species-responsive nanoprodrug with quinone methides-mediated GSH depletion for improved chlorambucil breast cancers therapy Journal of Controlled Release ·Cheng-Qiong Luo, Yuxin Zhou, Tian‐Jiao Zhou, Lei Xing, Peng‐Fei Cui, Minjie Sun, Na Lu, Hu‐Lin Jiang +1 other	2018	88
18	Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cells Blood ·Yan Chen, Hui Hui, Hao Yang, Kai Zhao, Yansu Qin, Xiaotang Wang, Na Lu, Qinglong Guo +1 other	2013	87
19	Reactive oxygen species accumulation contributes to gambogic acid-induced apoptosis in human hepatoma SMMC-7721 cells Toxicology ·Fei-Fei Nie, Xiaonan Zhang, Qi Qi, Lan‐Yan Yang, Yong Yang, Wei Liu, Na Lu, Zhao‐Qiu Wu	2009	84
20	Wogonin prevents lipopolysaccharide‐induced acute lung injury and inflammation in mice via peroxisome proliferator‐activated receptor gamma‐mediated attenuation of the nuclear factor‐kappaB pathway Immunology ·Jing Yao, Di Pan, Yue Zhao, Li Zhao, Jie Lena Sun, Yu Wang, Qi-Dong You, Tao Xi	2014	83

About Na Lu

Na Lu is a scholar working on Pharmacology, Cancer Research, Molecular Biology, Oncology and Biomaterials, having authored 155 papers that have together received 7.4k indexed citations. Recurring topics across this work include Flavonoids in Medical Research (74 papers), Natural Compound Pharmacology Studies (12 papers), Angiogenesis and VEGF in Cancer (12 papers), Cell death mechanisms and regulation (11 papers), Cancer, Hypoxia, and Metabolism (10 papers), Protease and Inhibitor Mechanisms (7 papers), Cancer-related Molecular Pathways (7 papers) and Glioma Diagnosis and Treatment (5 papers). The work is most often cited by research in Pharmacology (1.7k citations), Cancer Research (717 citations), Drug Discovery (11 citations), Complementary and alternative medicine (355 citations) and Oncology (712 citations). Na Lu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Qinglong Guo, Qi-Dong You, Qi Qi, Zhiyu Li, Yong Yang, Li Zhao, Xiuming Song, Hong-Yan Gu, Yue Zhao and Qinsheng Dai. Their work appears in journals such as Cancer Letters, Molecular Carcinogenesis, Oncotarget, Toxicology and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Na Lu

Impact in

Papers in i

In The Last Decade

Na Lu

Na Lu's Hit Papers

Peers

Countries citing papers authored by Na Lu

Fields of papers citing papers by Na Lu

All Works

About Na Lu

Explore authors with similar magnitude of impact

Papers in